Skip to Main ContentSkip to Footer

John A. Zic MD, MMHC

Professor of Dermatology
Insurance Plans Accepted

Areas of Expertise

  • Complex Medical Dermatology
  • Consultative Dermatology
  • Cutaneous T-Cell Lymphoma
  • Dermatology
  • General Adult Dermatology
  • Melanoma
  • Non-Melanoma Skin Cancer
  • Psoriasis

Conditions and Treatments

Location

Vanderbilt Dermatology
Vanderbilt Health One Hundred Oaks
719 Thompson Lane, Suite 26300
Nashville, TN 37204

Services

Languages

  • English

Education

  • Doctor of Medicine - Vanderbilt University, 1991
  • Internship - University of Chicago Medical Center, 1992
  • Residency - University of Illinois Medical Center, 1995
  • Management in Health Care - Vanderbilt University, 2017

Board Certifications

  • Dermatology - American Board of Dermatology, 1995

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Experience Survey and displayed in full. Patients are not identified in order to respect patient privacy.
Dr. Zic is an outstanding doctor! He is always great at listening to my concerns and questions. I would recommend him highly to anyone looking for a dermatologist!
September 25, 2026
Was finally seen by physician 1 hour and 11 minutes past my appointment time with no explanation why, other than I'm sorry!
September 25, 2026
Most thorough informative and gracious appointment ever
September 23, 2026
Having a trainee is a plus.
September 21, 2026
Dr. Zic is wonderful and so caring!!
September 18, 2026
Dr. Zic mentioned a potential skin issue which was borderline, leaving the decision to me. He also looked at my hand wound, said it was superficial, gave me instructions on how to care for it and instructed Brenda and Ophelia on how to redress it.
September 18, 2026
Dr Zic is absolutely amazing. I'm always grateful he's on my team.
September 16, 2026
Excellent
September 13, 2026
I cant say enough about Dr Zico's professionalism care and concern. He educated me about the procedure and communication was great throughout the procedure.
September 12, 2026